• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环基因异常细胞为鉴别肺结节≤10mm的肺癌患者增加了非侵入性诊断价值。

Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm.

作者信息

Ye Maosong, Zheng Xiaoxuan, Ye Xin, Zhang Juncheng, Huang Chuoji, Liu Zilong, Huang Meng, Fan Xianjun, Chen Yanci, Xiao Botao, Sun Jiayuan, Bai Chunxue

机构信息

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Respiratory Endoscopy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Front Oncol. 2021 Mar 11;11:638223. doi: 10.3389/fonc.2021.638223. eCollection 2021.

DOI:10.3389/fonc.2021.638223
PMID:33777797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7991838/
Abstract

BACKGROUND

Lung cancer screening using low-dose computed tomography (LDCT) often leads to unnecessary biopsy because of the low specificity among patients with pulmonary nodules ≤10 mm. Circulating genetically abnormal cells (CACs) can be used to discriminate lung cancer from benign lung disease. To examine the diagnostic value of CACs in detecting lung cancer for patients with malignant pulmonary nodules ≤10 mm.

METHODS

In this prospective study, patients with pulmonary nodules ≤10 mm who were detected at four hospitals in China from January 2019 to January 2020 were included. CACs were detected using fluorescence hybridization. All patients were confirmed as lung cancer or benign disease by further histopathological examination. Multivariable logistic regression models were established to detect the presence of lung cancer using CACs and other associated characteristics. Receiver operating characteristic analysis was used to evaluate the performance of CACs for lung cancer diagnosis.

RESULTS

Overall, 125 patients were included and analyzed. When the cutoff value of CACs was >2, the sensitivity and specificity for lung cancer were 70.5 and 86.4%. Male (OR = 0.330, P = 0.005), maximum solid nodule (OR = 2.362, P = 0.089), maximum nodule located in upper lobe (OR = 3.867, P = 0.001), and CACs >2 (OR = 18.525, P < 0.001) met the P < 0.10 criterion for inclusion in the multivariable models. The multivariable logistic regression model that included the dichotomized CACs (>2 ≤2) and other clinical factors (AUC = 0.907, 95% CI = 0.842-0.951) was superior to the models that only considered dichotomized CACs or other clinical factors and similar to the model with numerical CACs and other clinical factors (AUC = 0.913, 95% CI = 0.850-0.956).

CONCLUSION

CACs presented a significant diagnostic value in detecting lung cancer for patients with pulmonary nodules ≤10 mm.

摘要

背景

使用低剂量计算机断层扫描(LDCT)进行肺癌筛查时,由于≤10mm肺结节患者的特异性较低,常常导致不必要的活检。循环基因异常细胞(CACs)可用于区分肺癌与良性肺病。旨在研究CACs在检测≤10mm恶性肺结节患者肺癌中的诊断价值。

方法

在这项前瞻性研究中,纳入了2019年1月至2020年1月在中国四家医院检测出的≤10mm肺结节患者。使用荧光杂交检测CACs。所有患者均通过进一步的组织病理学检查确诊为肺癌或良性疾病。建立多变量逻辑回归模型,以利用CACs和其他相关特征检测肺癌的存在。采用受试者工作特征分析来评估CACs对肺癌诊断的性能。

结果

总共纳入并分析了125例患者。当CACs的截断值>2时,肺癌的敏感性和特异性分别为70.5%和86.4%。男性(OR = 0.330,P = 0.005)、最大实性结节(OR = 2.362,P = 0.089)、最大结节位于上叶(OR = 3.867,P = 0.001)以及CACs>2(OR = 18.525,P < 0.001)符合纳入多变量模型的P < 0.10标准。包含二分法CACs(>2与≤2)和其他临床因素的多变量逻辑回归模型(AUC = 0.907,95%CI = 0.842 - 0.951)优于仅考虑二分法CACs或其他临床因素的模型,且与包含数值型CACs和其他临床因素的模型相似(AUC = 0.913,95%CI = 0.850 - 0.956)。

结论

对于≤10mm肺结节患者,CACs在检测肺癌方面具有显著的诊断价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac3/7991838/9a6b4cb97abc/fonc-11-638223-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac3/7991838/644418d77647/fonc-11-638223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac3/7991838/b262478a1435/fonc-11-638223-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac3/7991838/9a6b4cb97abc/fonc-11-638223-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac3/7991838/644418d77647/fonc-11-638223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac3/7991838/b262478a1435/fonc-11-638223-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac3/7991838/9a6b4cb97abc/fonc-11-638223-g003.jpg

相似文献

1
Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm.循环基因异常细胞为鉴别肺结节≤10mm的肺癌患者增加了非侵入性诊断价值。
Front Oncol. 2021 Mar 11;11:638223. doi: 10.3389/fonc.2021.638223. eCollection 2021.
2
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.应用四色荧光原位杂交技术检测循环中遗传异常细胞用于肺癌的早期检测。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2397-2405. doi: 10.1007/s00432-021-03517-6. Epub 2021 Feb 6.
3
Precision patient selection for improved detection of circulating genetically abnormal cells in pulmonary nodules.精准选择患者以提高肺结节中循环遗传异常细胞的检测率。
Sci Rep. 2024 Sep 28;14(1):22532. doi: 10.1038/s41598-024-73542-1.
4
Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.循环遗传异常细胞对支持 CT 诊断良、恶性肺结节的价值。
BMC Cancer. 2022 Apr 9;22(1):382. doi: 10.1186/s12885-022-09472-w.
5
Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.检测外周血循环中遗传异常细胞用于非小细胞肺癌的早期诊断。
Thorac Cancer. 2020 Nov;11(11):3234-3242. doi: 10.1111/1759-7714.13654. Epub 2020 Sep 28.
6
The diagnostic value of circulating abnormal cells in early lung cancer.循环异常细胞在早期肺癌中的诊断价值。
Am J Cancer Res. 2023 Apr 15;13(4):1594-1601. eCollection 2023.
7
An efficient fluorescence in situ hybridization (FISH)-based circulating genetically abnormal cells (CACs) identification method based on Multi-scale MobileNet-YOLO-V4.一种基于多尺度MobileNet-YOLO-V4的高效荧光原位杂交(FISH)循环基因异常细胞(CACs)识别方法。
Quant Imaging Med Surg. 2022 May;12(5):2961-2976. doi: 10.21037/qims-21-909.
8
Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules.基于低剂量和标准剂量CT的影像组学模型对实性肺结节中腺癌和良性病变预测的比较
Front Oncol. 2021 Feb 2;10:634298. doi: 10.3389/fonc.2020.634298. eCollection 2020.
9
Risk assessment of malignancy in solitary pulmonary nodules in lung computed tomography: a multivariable predictive model study.肺 CT 孤立性肺结节恶性肿瘤风险评估:多变量预测模型研究。
Chin Med J (Engl). 2021 Jun 15;134(14):1687-1694. doi: 10.1097/CM9.0000000000001507.
10
Probability of cancer in pulmonary nodules detected on first screening CT.首次筛查 CT 检测到的肺结节的癌症概率。
N Engl J Med. 2013 Sep 5;369(10):910-9. doi: 10.1056/NEJMoa1214726.

引用本文的文献

1
An early lung cancer diagnosis model for non-smokers incorporating ct imaging analysis and circulating genetically abnormal cells (CACs).一种结合CT成像分析和循环基因异常细胞(CACs)的非吸烟者早期肺癌诊断模型。
BMC Cancer. 2025 Jan 22;25(1):124. doi: 10.1186/s12885-024-13268-5.
2
Precision patient selection for improved detection of circulating genetically abnormal cells in pulmonary nodules.精准选择患者以提高肺结节中循环遗传异常细胞的检测率。
Sci Rep. 2024 Sep 28;14(1):22532. doi: 10.1038/s41598-024-73542-1.
3
Analytical validation of the LungLB test: a 4-color fluorescence in-situ hybridization assay for the evaluation of indeterminate pulmonary nodules.

本文引用的文献

1
Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules.使用 4 色荧光原位杂交技术鉴定循环肿瘤细胞:验证一种非侵入性辅助方法,用于排除低剂量计算机断层扫描检测到肺部结节的患者的肺癌。
Cancer Cytopathol. 2020 Aug;128(8):553-562. doi: 10.1002/cncy.22278. Epub 2020 Apr 22.
2
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.NCCN 指南解读:非小细胞肺癌,第 1.2020 版。
J Natl Compr Canc Netw. 2019 Dec;17(12):1464-1472. doi: 10.6004/jnccn.2019.0059.
3
LungLB 检测的分析验证:一种用于评估肺部不确定结节的 4 色荧光原位杂交检测方法。
BMC Pulm Med. 2024 Sep 27;24(1):475. doi: 10.1186/s12890-024-03280-7.
4
Detection and identification of circulating tumor cells in parathyroid tumors and correlation analysis with clinicopathological features.甲状旁腺肿瘤中循环肿瘤细胞的检测与鉴定及其与临床病理特征的相关性分析。
Endocrine. 2024 Sep;85(3):1357-1364. doi: 10.1007/s12020-024-03831-2. Epub 2024 May 10.
5
Advances in diagnosis and prediction for aggression of pure solid T1 lung cancer.纯实性T1期肺癌侵袭性的诊断与预测进展
Precis Clin Med. 2023 Aug 17;6(3):pbad020. doi: 10.1093/pcmedi/pbad020. eCollection 2023 Sep.
6
Current and emerging applications of liquid biopsy in pan-cancer.液体活检在泛癌中的当前及新兴应用
Transl Oncol. 2023 Aug;34:101720. doi: 10.1016/j.tranon.2023.101720. Epub 2023 Jun 12.
7
The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules.血液中循环的遗传异常细胞的存在可预测肺内不确定结节个体的肺癌风险。
BMC Pulm Med. 2023 Jun 5;23(1):193. doi: 10.1186/s12890-023-02433-4.
8
The diagnostic value of circulating abnormal cells in early lung cancer.循环异常细胞在早期肺癌中的诊断价值。
Am J Cancer Res. 2023 Apr 15;13(4):1594-1601. eCollection 2023.
9
Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer.液体活检在早期非小细胞肺癌中的潜在临床应用。
BMC Med. 2022 Dec 14;20(1):480. doi: 10.1186/s12916-022-02681-x.
10
Editorial: Surgical Selection of Sublobar Resection and Scope of Lymph Node Dissection for Early-Stage Lung Cancer.社论:早期肺癌肺叶下切除的手术选择及淋巴结清扫范围
Front Surg. 2022 May 11;9:915220. doi: 10.3389/fsurg.2022.915220. eCollection 2022.
Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and F-FDG PET/CT in Correlation with Clinical Pathologic Outcome.
肺淋巴管癌病:高分辨率 CT 与 F-FDG PET/CT 对临床病理结局的诊断性能。
J Nucl Med. 2020 Jan;61(1):26-32. doi: 10.2967/jnumed.119.229575. Epub 2019 Jun 21.
4
Updated Fleischner Society Guidelines for Managing Incidental Pulmonary Nodules: Common Questions and Challenging Scenarios.更新版 Fleischner 学会肺部结节管理指南:常见问题和挑战性情况。
Radiographics. 2018 Sep-Oct;38(5):1337-1350. doi: 10.1148/rg.2018180017.
5
Evaluation of a Serum Lung Cancer Biomarker Panel.血清肺癌生物标志物组合的评估
Biomark Insights. 2018 Jan 15;13:1177271917751608. doi: 10.1177/1177271917751608. eCollection 2018.
6
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.IASLC 肺癌分期项目:第八版肺癌 TNM 分期中对亚实性结节 T 分期编码的建议和部分实性肿瘤肿瘤大小评估。
J Thorac Oncol. 2016 Aug;11(8):1204-1223. doi: 10.1016/j.jtho.2016.03.025. Epub 2016 Apr 21.
7
Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia.肺部结节评估:亚洲临床实践共识指南。
Chest. 2016 Oct;150(4):877-893. doi: 10.1016/j.chest.2016.02.650. Epub 2016 Feb 27.
8
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.肺癌六种血清肿瘤标志物联合检测的评估。
Am J Respir Crit Care Med. 2016 Feb 15;193(4):427-37. doi: 10.1164/rccm.201404-0603OC.
9
Using Clinical Risk Models for Lung Nodule Classification.使用临床风险模型进行肺结节分类。
Semin Thorac Cardiovasc Surg. 2015 Spring;27(1):30-5. doi: 10.1053/j.semtcvs.2015.04.001. Epub 2015 Apr 7.
10
Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.用于非小细胞肺癌早期检测的多重双分析物免疫测定法的性能
J Transl Med. 2015 Feb 12;13:55. doi: 10.1186/s12967-015-0419-y.